AI assistant
Sharp Therapeutics Corp. — Share Issue/Capital Change 2025
Jan 27, 2025
48457_rns_2025-01-27_9b07ff46-bfe6-4d95-ab7a-b6530658cf92.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Ontario
Ministry of Public and
Business Service Delivery
Ministère des Services au public et
aux entreprises
Certificate of Amendment
Certificat de modification
Business Corporations Act
Loi sur les sociétés par actions
SHARP THERAPEUTICS CORP.
Corporation Name / Dénomination sociale
2871161
Ontario Corporation Number / Numéro de société de l'Ontario
This is to certify that these articles are effective on
La présente vise à attester que ces statuts entreront en vigueur le
January 27, 2025 / 27 janvier 2025
V. Quintanilla W.
Director / Directeur
Business Corporations Act / Loi sur les sociétés par actions
The Certificate of Amendment is not complete without the Articles of Amendment
Certified a true copy of the record of the Ministry of Public and Business Service Delivery.
V. Quintanilla W.
Director/Registrar

Ce certificat de modification n'est pas complet s'il ne contient pas les statuts de modification
Copie certifiée conforme du dossier du ministère des Services au public et aux entreprises.
V. Quintanilla W.
Directeur ou registrateur
BCA - Articles of Amendment - SHARP THERAPEUTICS CORP. - OCN:2871161 - January 27, 2025
Ontario
Ministry of Public and Business Service Delivery
Articles of Amendment
Business Corporations Act
Corporation Name (Date of Incorporation/Amalgamation)
SHARP THERAPEUTICS CORP. (October 04, 2021)
-
The name of the corporation is changed to:
Not amended -
The number of directors or the minimum/maximum number of directors are amended as follows:
Not amended -
The articles are amended as follows:
A. Restrictions, if any, on business the corporation may carry on or on powers the corporation may exercise. If none, enter "None":
Not amended
B. The classes and any maximum number of shares that the corporation is authorized to issue:
-
To consolidate all of the issued and outstanding common shares of the Corporation on the basis of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares of the Corporation.
-
In the event that the consolidation of the common shares would otherwise result in the issuance of fractional shares, no fractional common shares of the Corporation shall be issued and such fractions will be rounded up to the nearest whole number and no cash consideration shall be paid.
The endorsed Articles of Amendment are not complete without the Certificate of Amendment.
Certified a true copy of the record of the Ministry of Public and Business Service Delivery.
V. Quinlanilla W.
Director/Registrar, Ministry of Public and Business Service Delivery
BCA - Articles of Amendment - SHARP THERAPEUTICS CORP. - OCN:2871161 - January 27, 2025
C. Rights, privileges, restrictions and conditions (if any) attaching to each class of shares and directors' authority with respect to any class of shares which may be issued in series. If there is only one class of shares, enter "Not Applicable": Not amended
D. The issue, transfer or ownership of shares is/is not restricted and the restrictions (if any) are as follows. If none, enter "None": Not amended
E. Other provisions: Not amended
-
The amendment has been duly authorized as required by sections 168 and 170 (as applicable) of the Business Corporations Act.
-
The resolution authorizing the amendment was approved by the shareholders/directors (as applicable) of the corporation on: December 06, 2024
The articles have been properly executed by the required person(s).
The endorsed Articles of Amendment are not complete without the Certificate of Amendment. Certified a true copy of the record of the Ministry of Public and Business Service Delivery.
V. Quinlanilla W.
Director/Registrar, Ministry of Public and Business Service Delivery
Page 2 of 2